# FDA 483 - Aslan T Turer, M.D. - August 16, 2023

Source: https://www.globalkeysolutions.net/records/483/aslan-t-turer-md/43c7e98b-ac0a-493e-a05e-a72806d4f102

> FDA 483 for Aslan T Turer, M.D. on August 16, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Aslan T Turer, M.D.
- Inspection Date: 2023-08-16
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Aslan T Turer, M.D. in Dallas, TX, from August 8-16, 2023, revealed significant deficiencies in maintaining adequate case histories for a clinical study on Hypertrophic Cardiomyopathy. The clinical investigator failed to properly document reviews of laboratory reports, ECGs, echocardiograms, dose adjustments, and adverse event inquiries for study subjects. These issues indicate a lack of adherence to protocol requirements and proper record-keeping practices.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/travis-m-beard/a89f6d0b-dc5b-4adc-84f5-36e04b00fc2d)

Company: https://www.globalkeysolutions.net/companies/aslan-t-turer-md/8a043e70-82fd-4923-841a-79c93a23e485

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab